Pheton Holdings Ltd Class A Ordinary Shares (PTHL)

CN — Healthcare Sector
Peers: DHAI  IINN  PAVM  TNON  BMRA  POAI  VSEE  BNR  SSKN  HSCS 

Automate Your Wheel Strategy on PTHL

With Tiblio's Option Bot, you can configure your own wheel strategy including PTHL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol PTHL
  • Rev/Share 0.0315
  • Book/Share 0.434
  • PB 1.4078
  • Debt/Equity 0.0401
  • CurrentRatio 12.3993
  • ROIC -0.1308

 

  • MktCap 8712157.0
  • FreeCF/Share -0.0544
  • PFCF -11.229
  • PE -13.1803
  • Debt/Assets 0.0369
  • DivYield 0
  • ROE -0.2131

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 1
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Pheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors
PTHL
Published: August 01, 2025 by: GlobeNewsWire
Sentiment: Neutral

BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company,” “we,” “our” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today issued the following statements in response to recent market volatility and a third-party publication that has raised questions and concerns among shareholders.

Read More
image for news Pheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors

About Pheton Holdings Ltd Class A Ordinary Shares (PTHL)

  • IPO Date
  • Website https://www.ftzy.com.cn
  • Industry Medical - Devices
  • CEO Jianfei Zhang
  • Employees 10
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.